Key facts
- Ruminant BioTech’s last known valuation is $74.8M (Nov 2025).
- It has raised $17.2M; the latest was Early Stage VC ($9.6M) in Nov 2025.
- Notable investors include AgResearch(New Zealand), Agmardt, AgriZeroNZ, Akina (NZ), Centre for Climate Action Joint Venture — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Ruminant BioTech
- ·The full record, as it builds
Funding rounds
No funding rounds for Ruminant BioTech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ruminant BioTech
Developer of a slow-release device designed for long-term controlled-release methane mitigation. The company's device contains a naturally occurring organic compound to deliver high levels of methane knockdown over that time period, enabling farmers to reduce greenhouse gas emissions.
- Sector
- Materials and Resources
- HQ
- Auckland, New Zealand
- Founded
- 2021
- Employees
- 21
- Website
- ruminantbiotech.com/
- Ownership
- Privately Held (backing)
Ruminant BioTech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ruminant BioTech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ruminant BioTech in its N-PORT filings yet. We sweep new filings monthly.